Zelluna ASA (OSL:ZLNA)

Norway flag Norway · Delayed Price · Currency is NOK
9.37
+0.12 (1.25%)
At close: Dec 5, 2025
Market Cap 191.55M
Revenue (ttm) 53.00K
Net Income (ttm) -122.19M
Shares Out 20.45M
EPS (ttm) -30.91
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16,374
Average Volume 20,154
Open 9.80
Previous Close 9.25
Day's Range 8.70 - 9.80
52-Week Range 8.20 - 22.50
Beta n/a
RSI 46.91
Earnings Date Feb 12, 2026

About Zelluna ASA

Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 22
Stock Exchange Oslo Børs
Ticker Symbol ZLNA
Full Company Profile

Financial Performance

Financial Statements

News

Zelluna ASA (OSL:ZLNA) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Insights

Zelluna ASA (OSL:ZLNA) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Insights

4 weeks ago - GuruFocus

Q3 2025 Zelluna ASA Earnings Call Transcript

Q3 2025 Zelluna ASA Earnings Call Transcript

4 weeks ago - GuruFocus